by Rick Waines, British Columbia In 1983 I was 17 and attended my first WFH meeting in Stockholm, Sweden, and at the opening plenary Dr....
In a letter to the European Haemophilia Consortium dated May 31, 2022, Ferring Pharmaceuticals informed the bleeding disorder community that Octostim (desmopressin) Nasal Spray 1.5...
by Wendy Quinn, CHS President A few days ago I received an e-mail with the subject “Exciting news and accomplishments in BC.” I immediately opened...
March 30, 2022, Ottawa – Canadian Blood Services’ contracts with suppliers of recombinant factor VIII and IX for the 2022-2025 period take effect on April...
by David Page, CHS National Director of Health Policy The Canadian Hemophilia Society (CHS), its chapters and members have expended great efforts to advocate for...